Clinical Trial Update: Cilengitide in Treating Children With Refractory Primary Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of cilengitide in children with refractory primary brain tumors has completed; the study explored safety, dosing, and tolerability across multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma High Grade
• Choroid Plexus Tumor
• Craniopharyngioma
• Ependymoma
• Germinoma
• Medulloblastoma
• Meningioma
• Oligodendroglioma

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor | Phase 1 | Status: COMPLETED